Subscribe free

Metabolic and Bariatric Surgery ·

Bariatric Surgery Rescues Weight Loss After GLP-1 Failure

Patients who stopped semaglutide or tirzepatide and then had bariatric surgery still lost substantial weight over two years, with gastric bypass doing better after inadequate response.

  • Among 268 patients who stopped the drugs for intolerance or poor response, 2-year weight loss was 22.7% to 35.8% after surgery, depending on procedure and diabetes status.
  • After inadequate response, gastric bypass gave 14.9 percentage points more total weight loss than sleeve gastrectomy (32.7% vs. 17.8%) in adjusted analysis.

This retrospective Cleveland Clinic cohort supports bariatric surgery as a rescue option, with gastric bypass favored after inadequate response. Surgery in patients previously on these drugs should be judged against comparison data, since the study has no randomized control.

Journal Article by Aminian A, Hammad AF (…) Nissen SE et 5 al. in Ann Surg

Copyright © 2026 The Author(s). Published by Wolters Kluwer Health, LLC.

read the whole article in Ann Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Metabolic and Bariatric Surgery.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Metabolic and Bariatric Surgery

The latest stitches

Surg Endosc29 Sep 2026

Endoscopic Sleeve Gastroplasty Offers Safer Alternative to LSG

Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).

All papers in Metabolic and Bariatric Surgery →